SI2032534T1 - 4-((3-fluorofenoksi)fenilmetil)piperidin metansulfonat: raba, postopek sintetiziranja in farmacevtske zmesi - Google Patents
4-((3-fluorofenoksi)fenilmetil)piperidin metansulfonat: raba, postopek sintetiziranja in farmacevtske zmesiInfo
- Publication number
- SI2032534T1 SI2032534T1 SI200730543T SI200730543T SI2032534T1 SI 2032534 T1 SI2032534 T1 SI 2032534T1 SI 200730543 T SI200730543 T SI 200730543T SI 200730543 T SI200730543 T SI 200730543T SI 2032534 T1 SI2032534 T1 SI 2032534T1
- Authority
- SI
- Slovenia
- Prior art keywords
- fluorophenoxy
- phenylmethyl
- synthesis
- pharmaceutical compositions
- åpiperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Addiction (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06380112A EP1854785A1 (en) | 2006-05-12 | 2006-05-12 | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
US11/486,350 US20070265306A1 (en) | 2006-05-12 | 2006-07-13 | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
EP07728049A EP2032534B1 (en) | 2006-05-12 | 2007-04-12 | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
PCT/EP2007/053582 WO2007131846A1 (en) | 2006-05-12 | 2007-04-12 | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2032534T1 true SI2032534T1 (sl) | 2011-06-30 |
Family
ID=37061190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200730543T SI2032534T1 (sl) | 2006-05-12 | 2007-04-12 | 4-((3-fluorofenoksi)fenilmetil)piperidin metansulfonat: raba, postopek sintetiziranja in farmacevtske zmesi |
Country Status (24)
Country | Link |
---|---|
US (2) | US20070265306A1 (sl) |
EP (2) | EP1854785A1 (sl) |
JP (1) | JP2009536962A (sl) |
KR (1) | KR20090009971A (sl) |
CN (1) | CN101443312B (sl) |
AT (1) | ATE501121T1 (sl) |
AU (1) | AU2007251663B2 (sl) |
BR (1) | BRPI0710856A2 (sl) |
CA (1) | CA2651933A1 (sl) |
CY (1) | CY1111460T1 (sl) |
DE (1) | DE602007013040D1 (sl) |
DK (1) | DK2032534T3 (sl) |
ES (1) | ES2362683T3 (sl) |
HK (1) | HK1130053A1 (sl) |
HR (1) | HRP20110333T1 (sl) |
MX (1) | MX2008014439A (sl) |
MY (1) | MY148406A (sl) |
NO (1) | NO20085052L (sl) |
NZ (1) | NZ572714A (sl) |
PL (1) | PL2032534T3 (sl) |
RS (1) | RS51858B (sl) |
RU (1) | RU2412169C2 (sl) |
SI (1) | SI2032534T1 (sl) |
WO (1) | WO2007131846A1 (sl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1854785A1 (en) * | 2006-05-12 | 2007-11-14 | Faes Farma, S.A. | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
JP5405571B2 (ja) * | 2008-07-24 | 2014-02-05 | セラヴァンス, インコーポレーテッド | 3−(フェノキシフェニルメチル)ピロリジン化合物 |
JP2012524098A (ja) * | 2009-04-15 | 2012-10-11 | セラヴァンス, インコーポレーテッド | 3−(フェノキシピロリジン−3−イル−メチル)ヘテロアリール、3−(フェニルピロリジン−3−イルメトキシ)ヘテロアリールおよび3−(ヘテロアリールピロリジン−3−イルメトキシ)ヘテロアリール化合物 |
JP5826173B2 (ja) | 2009-07-13 | 2015-12-02 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 3−フェノキシメチルピロリジン化合物 |
JP5714580B2 (ja) | 2009-07-21 | 2015-05-07 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 3−フェノキシメチルピロリジン化合物 |
CN103153950B (zh) | 2010-10-11 | 2015-11-25 | 施万生物制药研发Ip有限责任公司 | 血清素再摄取抑制剂 |
US8501964B2 (en) | 2010-12-03 | 2013-08-06 | Theravance, Inc. | Serotonin reuptake inhibitors |
US9002322B2 (en) * | 2011-09-29 | 2015-04-07 | Apple Inc. | Authentication with secondary approver |
CN104887675B (zh) * | 2014-03-05 | 2018-08-07 | 江苏恩华药业股份有限公司 | [(芳氧基)(杂芳基)]甲基哌啶衍生物在制备治疗抑郁症的药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1203149A (en) * | 1968-06-10 | 1970-08-26 | Ici Ltd | Piperidine derivatives |
US6518284B2 (en) * | 1998-11-18 | 2003-02-11 | Faes, Fabrica Espanola De Productos Quimicos Y Farmaceuticos S.A. | 4-substituted piperidines |
ES2157148B1 (es) * | 1998-11-18 | 2002-03-01 | Faes Fabrica Espanola De Produ | Nuevas piperidinas 4-sustituidas. |
JP4185154B2 (ja) * | 2004-04-30 | 2008-11-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 中枢神経系障害治療用の置換モルホリン化合物 |
EP1854785A1 (en) * | 2006-05-12 | 2007-11-14 | Faes Farma, S.A. | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
-
2006
- 2006-05-12 EP EP06380112A patent/EP1854785A1/en not_active Withdrawn
- 2006-07-13 US US11/486,350 patent/US20070265306A1/en not_active Abandoned
-
2007
- 2007-04-12 MX MX2008014439A patent/MX2008014439A/es active IP Right Grant
- 2007-04-12 SI SI200730543T patent/SI2032534T1/sl unknown
- 2007-04-12 JP JP2009510383A patent/JP2009536962A/ja not_active Ceased
- 2007-04-12 CN CN2007800172665A patent/CN101443312B/zh not_active Expired - Fee Related
- 2007-04-12 KR KR1020087030170A patent/KR20090009971A/ko not_active Application Discontinuation
- 2007-04-12 DE DE602007013040T patent/DE602007013040D1/de active Active
- 2007-04-12 RU RU2008148941/04A patent/RU2412169C2/ru not_active IP Right Cessation
- 2007-04-12 DK DK07728049.3T patent/DK2032534T3/da active
- 2007-04-12 US US12/299,907 patent/US20100004283A1/en not_active Abandoned
- 2007-04-12 MY MYPI20084507A patent/MY148406A/en unknown
- 2007-04-12 EP EP07728049A patent/EP2032534B1/en active Active
- 2007-04-12 NZ NZ572714A patent/NZ572714A/en not_active IP Right Cessation
- 2007-04-12 AT AT07728049T patent/ATE501121T1/de active
- 2007-04-12 CA CA002651933A patent/CA2651933A1/en not_active Abandoned
- 2007-04-12 AU AU2007251663A patent/AU2007251663B2/en not_active Ceased
- 2007-04-12 BR BRPI0710856-7A patent/BRPI0710856A2/pt not_active IP Right Cessation
- 2007-04-12 ES ES07728049T patent/ES2362683T3/es active Active
- 2007-04-12 PL PL07728049T patent/PL2032534T3/pl unknown
- 2007-04-12 RS RS20110154A patent/RS51858B/en unknown
- 2007-04-12 WO PCT/EP2007/053582 patent/WO2007131846A1/en active Application Filing
-
2008
- 2008-12-04 NO NO20085052A patent/NO20085052L/no not_active Application Discontinuation
-
2009
- 2009-09-03 HK HK09108045.9A patent/HK1130053A1/xx not_active IP Right Cessation
-
2011
- 2011-05-06 HR HR20110333T patent/HRP20110333T1/hr unknown
- 2011-05-17 CY CY20111100477T patent/CY1111460T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2032534B1 (en) | 2011-03-09 |
KR20090009971A (ko) | 2009-01-23 |
AU2007251663A1 (en) | 2007-11-22 |
DK2032534T3 (da) | 2011-04-26 |
MY148406A (en) | 2013-04-30 |
RU2008148941A (ru) | 2010-06-20 |
EP2032534A1 (en) | 2009-03-11 |
CN101443312A (zh) | 2009-05-27 |
CA2651933A1 (en) | 2007-11-22 |
EP1854785A1 (en) | 2007-11-14 |
JP2009536962A (ja) | 2009-10-22 |
HRP20110333T1 (hr) | 2011-06-30 |
ATE501121T1 (de) | 2011-03-15 |
WO2007131846A1 (en) | 2007-11-22 |
PL2032534T3 (pl) | 2011-08-31 |
CY1111460T1 (el) | 2015-08-05 |
US20100004283A1 (en) | 2010-01-07 |
AU2007251663B2 (en) | 2012-04-05 |
NO20085052L (no) | 2008-12-04 |
BRPI0710856A2 (pt) | 2011-05-17 |
US20070265306A1 (en) | 2007-11-15 |
MX2008014439A (es) | 2009-01-21 |
RS51858B (en) | 2012-02-29 |
NZ572714A (en) | 2010-08-27 |
CN101443312B (zh) | 2011-07-06 |
ES2362683T3 (es) | 2011-07-11 |
RU2412169C2 (ru) | 2011-02-20 |
HK1130053A1 (en) | 2009-12-18 |
DE602007013040D1 (de) | 2011-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1130053A1 (en) | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
TNSN06409A1 (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
MX2010006179A (es) | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico. | |
EA200970090A1 (ru) | Модуляторы метаболизма и лечение связанных с ним расстройств | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
GEP20156366B (en) | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use | |
PT2150530E (pt) | Derivados de sulfonamida substituídos | |
CY1115058T1 (el) | Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης | |
NO20070089L (no) | DPP-IV inhibitorer | |
NO20091185L (no) | Piperidinderivater | |
HK1146049A1 (en) | Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 | |
IL193252A0 (en) | N-hydroxyacrylamide compounds | |
EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
MX2009004386A (es) | Compuestos inhibidores de proteina de transferencia de trigliceridos microsomales de acido tetrahidro-naftalen-1-carboxil ico sustituidos con piperidina o piperazina. | |
EA201071269A1 (ru) | 3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина | |
TN2009000452A1 (en) | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof | |
WO2008087654A3 (en) | PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
MX2009012518A (es) | Derivados de piperidina 4,4-disubstituidos. | |
MX2009002906A (es) | Derivados de piridina para el tratamiento de trastornos metabolicos relacionados con la resistencia a insulina o hiperglicemia. | |
BRPI0517734A (pt) | derivados de 1-[(6,7-alcoxiquinoxalinil substituìdo) aminocarbonil]-4- (hetero) arilpiperazina | |
NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
NO20092400L (no) | 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) indole compounds and their use as 5-HT6 Ligands | |
DK2200980T3 (da) | Aminoarylsulfonamidforbindelser og deres anvendelse som 5-HT6-ligander |